Jennifer L Taubert sold $10.0M of Johnson & Johnson (JNJ)

Executed Sep 4 2025, disclosed Sep 5 2025, 1 day later.

Value, as filed

$10.0M

56,471 sh × $177.81

Executed

Sep 4 2025

the trade date, as filed

Disclosed

Sep 5 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

JT Jennifer L Taubert EVP, WWC. Innovative Medicine profile →

Jennifer L Taubert (EVP, WWC. Innovative Medicine) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Johnson & Johnson (JNJ). The largest single filing was $4.0M of JNJ (15,000 sh × $263.36, as filed), executed Aug 17.

The name

JNJ Johnson & Johnson JNJ · Healthcare · 86 filings in 24 months ticker →

Healthcare · Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jennifer L Taubert in JNJ

JNJSALE Johnson & Johnson $4.0M
15,000 sh × $263.36
Exec Aug 17
Filed Aug 18 · 6:31 PM ET